HAL (France)open access
Effects of Finerenone Across a Range of Heart Failure Duration: A Prespecified Analysis of the FINEARTS-HF Trial
Heart failure with mildly reduced ejection fraction, Finerenone, Mineralocorticoid receptor antagonists, 0, Heart failure with 1 preserved ejection fraction
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 126834
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.